Sunday, October 9, 2016

AstraZeneca, Rivals Take Aim at Lung Cancer With Combo Therapies

… combination treatment for non-small cell lung cancer, said Sean Bohen, chief medical … have showed early promise in lung cancer. Cambridge, England-based AstraZeneca has the … and conventional chemotherapy tested on lung cancer patients. The results showed the …

No comments:

Post a Comment